Trialbee's Smart Patient Matching drives 30% referral conversion rate
A large global pharma initiated a phase III study testing the efficacy of combining two existing drugs in overactive bladder patients.
Offered Free by: Trialbee AB
See All Resources from: Trialbee AB
This download should complete shortly. If the resource doesn't automatically download, please, click here.